Get started
Author

Chanchai Charonpongsuntorn

Observed names: C. Charonpongsuntorn, Charonpongsuntorn Chanchai, Charonpongsuntorn, Chanchai
ORCID: 0000-0001-8710-1020
Observed ORCID: 0000-0001-8710-1020
OpenAlex ID: A5060853148
Stress and associated factors with received and needed support in medical students during COVID-19 pandemic: a multicenter study
2021 · Tidarat Puranachaikere, Somboon Hataiyusuk, et al. · Korean journal of medical education · 25
PDF
Efficacy, Safety, and Patient-Reported Outcomes of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Thailand: A Multicenter Prospective Study
2022 · Chanchai Charonpongsuntorn, Suebpong Tanasanvimon, et al. · JCO Global Oncology · 17
Clinical Prognostic Factors and Treatment Outcomes for the Survival of Patients with Cholangiocarcinoma in the Eastern Region of Thailand
2019 · Charonpongsuntorn Chanchai, Piyanuch Piyasatit, et al. · Asian Pacific Journal of Cancer Care · 11
PDF
Cost-utility analysis of atezolizumab combined with bevacizumab for unresectable hepatocellular carcinoma in Thailand
2024 · Supachaya Sriphoosanaphan, Witthawat Pantumongkol, et al. · PLoS ONE · 8
PDF
Role of BIM Deletion Polymorphism and BIM Expression as Predictive Biomarkers to Maximize the Benefit of EGFR-TKI Treatment in EGFR-Positive NSCLC
2019 · Pimpin Incharoen, Chanchai Charonpongsuntorn, et al. · Asian Pacific Journal of Cancer Prevention · 8
PDF
Overoxidized electropolymerized poly(pyrrole-1-propionic acid) on screen-printed graphene electrode-based electrochemical sensor for selective detection of dopamine neurotransmitters in the presence of norepinephrine and serotonin
2025 · Jeerakit Thangphatthanarungruang, Wichayaporn Kamsong, et al. · Electrochemistry Communications · 7
Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing biliary tract cancer (BTC) and pancreatic cancer (PC): Outcomes from DESTINY-PanTumor02 (DP-02).
2024 · Do-Youn Oh, Iwona A. Lugowska, et al. · Journal of Clinical Oncology · 6
Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing biliary tract or pancreatic tumors: a subgroup analysis of DESTINY-PanTumor02
2026 · D.-Y. Oh, I. Ługowska, et al. · ESMO Open · 2
PDF
Integrating monolithic sorbent micro-solid-phase extraction with anodized screen-printed graphene electrode for serotonin neurotransmitter detection in the presence of ascorbic acid and uric acid
2026 · Jeerakit Thangphatthanarungruang, Wichayaporn Kamsong, et al. · Microchimica Acta · 2
1566P Sleep quality and depression in cancer patients receiving systemic chemotherapy: A prospective study
2022 · C. Charonpongsuntorn, P. Tiranaprakij, et al. · Annals of Oncology · 2
Efficacy and Safety of Durvalumab plus Tremelimumab for Unresectable Hepatocellular Carcinoma: A Real-World Multicenter Observational Study
2026 · Krittiya Korphaisarn, Kosin Wirasorn, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 1
PDF
MO5-3 Efficacy and patient-report outcomes of atezolizumab/ bevacizumab for unresectable hepatocellular carcinoma in Thailand
2022 · Chanchai Charonpongsuntorn, Suebpong Tanasanvimon, et al. · Annals of Oncology · 1
1864P Prospective cohort study on efficacy of topical capsaicin as treatment of chemotherapy-induced peripheral neuropathy
2020 · C. Charonpongsuntorn, P. Yottasan · Annals of Oncology · 1
Analysis of prognostic factors and treatment outcomes for survival in hepatocellular carcinoma patients
2019 · Chanchai Charonpongsuntorn · Annals of Oncology · 1
P3.02b-017 Sequence of EGFR-TKI Therapy and BIM Deletion Polymorphism Affect the Outcome of Treatment in EGFR Positive NSCLC
2017 · Chanchai Charonpongsuntorn, Pimpin Incharoen, et al. · Journal of Thoracic Oncology · 1
Sleep quality and depression in patients with cancer receiving chemotherapy: a prospective observational study at a university hospital in Thailand
2026 · Pornkamol Tiranaprakij, Panunat Muangnoi, et al. · BMJ Open
Serum 25-hydroxyvitamin D and overall survival in cholangiocarcinoma, hepatocellular carcinoma, and pancreatic cancer: A Thai cohort study
2026 · Chanchai Charonpongsuntorn, Napat Mittparian, et al. · World Journal of Gastrointestinal Oncology
Landscape of industry-sponsored oncology trials across the Thai Society of Clinical Oncology (TSCO): a 12-year multicenter analysis
2026 · Kosin Wirasorn, Jirapath Wiwitkeyoonwong, et al. · BMC Cancer
Real-world effectiveness of NALIRIFOX versus modified FOLFIRINOX or gemcitabine and nab-paclitaxel in first-line advanced pancreatic adenocarcinoma: a multicentre propensity-matched study
2026 · Tawasapon Thambamroong, Ratchadakorn Meesart, et al. · BMJ Oncology
PDF
The Efficacy of Dexamethasone Versus N‐Acetylcysteine in Prevention of Post‐Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double‐Blind, Double‐Dummy, Non‐Inferiority Trial
2026 · Padungkeat Karasin, Kittithat Tantitanawat, et al. · Asia-Pacific Journal of Clinical Oncology
1151P Landscape and performance of industry-sponsored oncology trials in Thailand: A Thai Society of Clinical Oncology (TSCO) multicenter analysis
2025 · J. Juengsamarn, J. Wiwitkeyoonwong, et al. · Annals of Oncology
894eP Serum 25(OH)D and mortality risk in cholangiocarcinoma, HCC, and pancreatic cancer: Single-institution experience
2025 · N. Poonyarangsarit, C. Charonpongsuntorn, et al. · Annals of Oncology
2239P Real-world efficacy and safety of NALIRIFOX versus modified-FOLFIRINOX or gemcitabine and nab-paclitaxel in metastatic pancreatic adenocarcinoma: A propensity score-matched cohort study
2025 · T. Thambamroong, C. Akewanlop, et al. · Annals of Oncology
368eP Real-world outcomes of nanoliposomal irinotecan plus fluorouracil in second-line treatment of advanced pancreatic cancer: A multicenter retrospective study from Thailand
2025 · T. Thambamroong, C. Sathitruangsak, et al. · Annals of Oncology
PDF
Real-world data of durvalumab plus gemcitabine and cisplatin in patients with advanced biliary tract cancer: A Thailand multicenter observational study.
2025 · Suebpong Tanasanvimon, Kunlatida Maneenil, et al. · Journal of Clinical Oncology
Works count: 32
Citation count: 93
H-index: 6
I10-index: 3
Year
Topic
Type